[DOWNLOAD] "Use of Ozone-Depleting Substances - Removal of Essential-Use Designation (Epinephrine) - Notice of Final Rule (US Food and Drug Administration Regulation) (FDA) (2018 Edition)" by The Law Library * eBook PDF Kindle ePub Free
eBook details
- Title: Use of Ozone-Depleting Substances - Removal of Essential-Use Designation (Epinephrine) - Notice of Final Rule (US Food and Drug Administration Regulation) (FDA) (2018 Edition)
- Author : The Law Library
- Release Date : January 17, 2018
- Genre: Law,Books,Professional & Technical,
- Pages : * pages
- Size : 224 KB
Description
The Law Library presents the complete text of the Use of Ozone-Depleting Substances - Removal of Essential-Use Designation (Epinephrine) - Notice of Final Rule (US Food and Drug Administration Regulation) (FDA) (2018 Edition).
Updated as of May 29, 2018
The Food and Drug Administration (FDA), after consultation with the Environmental Protection Agency (EPA), is amending FDA's regulation on the use of ozone-depleting substances (ODSs) in self-pressurized containers to remove the essential-use designation for epinephrine used in oral pressurized metered-dose inhalers (MDIs). The Clean Air Act requires FDA, in consultation with the EPA, to determine whether an FDA-regulated product that releases an ODS is an essential use of the ODS. FDA has concluded that there are no substantial technical barriers to formulating epinephrine as a product that does not release ODSs, and therefore epinephrine would no longer be an essential use of ODSs as of December 31, 2011. Epinephrine MDIs containing an ODS cannot be marketed after this date.
This ebook contains:
- The complete text of the Use of Ozone-Depleting Substances - Removal of Essential-Use Designation (Epinephrine) - Notice of Final Rule (US Food and Drug Administration Regulation) (FDA) (2018 Edition)
- A dynamic table of content linking to each section
- A table of contents in introduction presenting a general overview of the structure